- Home
- AUPH vs AMN Comparison
AUPH vs AMN Comparison
Compare AUPH & AMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- AMN
- Stock Information
- Founded
- AUPH 1993
- AMN 1985
- Country
- AUPH Canada
- AMN United States
- Employees
- AUPH N/A
- AMN N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- AMN Assisted Living Services
- Sector
- AUPH Health Care
- AMN Health Care
- Exchange
- AUPH Nasdaq
- AMN Nasdaq
- Market Cap
- AUPH 1.0B
- AMN 936.6M
- IPO Year
- AUPH 1999
- AMN 2001
- Fundamental
- Price
- AUPH $8.12
- AMN $23.70
- Analyst Decision
- AUPH Strong Buy
- AMN Hold
- Analyst Count
- AUPH 3
- AMN 8
- Target Price
- AUPH $10.33
- AMN $48.33
- AVG Volume (30 Days)
- AUPH 1.3M
- AMN 1.3M
- Earning Date
- AUPH 11-07-2024
- AMN 11-07-2024
- Dividend Yield
- AUPH N/A
- AMN N/A
- EPS Growth
- AUPH N/A
- AMN N/A
- EPS
- AUPH N/A
- AMN 1.39
- Revenue
- AUPH $220,361,000.00
- AMN $3,067,341,000.00
- Revenue This Year
- AUPH $36.52
- AMN N/A
- Revenue Next Year
- AUPH $19.02
- AMN N/A
- P/E Ratio
- AUPH N/A
- AMN $17.05
- Revenue Growth
- AUPH 38.72
- AMN N/A
- 52 Week Low
- AUPH $4.71
- AMN $23.39
- 52 Week High
- AUPH $10.05
- AMN $80.22
- Technical
- Relative Strength Index (RSI)
- AUPH 62.64
- AMN 19.75
- Support Level
- AUPH $8.06
- AMN $36.75
- Resistance Level
- AUPH $8.70
- AMN $42.41
- Average True Range (ATR)
- AUPH 0.34
- AMN 2.34
- MACD
- AUPH 0.07
- AMN -1.51
- Stochastic Oscillator
- AUPH 63.74
- AMN 1.63
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About AMN AMN Healthcare Services Inc
AMN Healthcare Services is one of the largest healthcare staffing company in the United States. In 2023, it offered more than 13,000 nurses and allied healthcare full-time workers with provider clients nationwide. About two thirds of its business is generated from its temporary nursing division; the other third is generated from its physician placement and technology-backed workplace solutions divisions.